
Dr. David G. Davtyan is one of the most experienced and successful LapBand® surgeons in the U.S. and a prominent and respected surgeon in Los Angeles. His deep understanding of the gastric banding procedure is related to the fact that he is a LapBand® patient himself. He specializes in several procedures such as gastric banding surgery, LAP-BAND Surgery, bariatric surgery and obesity surgery. Dr. Davtyan studied the LAP-BAND® procedure in the exact place where it was first introduced: in Brussels, Belgium. He performed his first LAP-BAND® intervention in October 2001 in Brussels with one of the LAP-BAND® pioneers himself, namely Professor Guy-Bernard Cadiere. In fact, Dr. Davtyan was one of the first surgeons in the United States to offer the LAP-BAND® after FDA approved it, in April 2001.
Procedures Dr. David Davtyan Performs at Marina del Rey Hospital
Insurance Accepted
- Aetna
- Blue Cross / Blue Shield
- Cigna
- HealthNet
- The Guardian Life Insurance Company of America
Languages Spoken
- English
- French
- Russian
- Spanish
Education & Training

Medical Degree
David Geffen School of Medicine at UCLA

Internship(s)
Anderson Cancer Center - General Surgery
University of Texas Houston: Department of Surgery

Residency(ies)
Anderson Cancer Center - General Surgery
University of Texas Houston: Department of Surgery

Fellowship(s)
UCLA Department of Surgery: American Cancer Society Clinical and Research Fellowship - Surgical Oncology
John Wayne Cancer Institute: National Institute of Health Clinical and Research Fellowship - Surgical Oncology
Honors & Awards
Memberships & Affiliations


Publications & Media
-
Wernicke’s encephalopathy in AIDS patient treated with Zidovudine (AZT)
Davtyan DG, Vinters H, Lancet 1987, 1: 919-920
-
A Lap-Band Revolution
Dr. Davtyan’s Personal WLS Journey. OH Magazine, 2006(2)
-
Surgical Treatment of Obesity: Questions Physicians Often Ask About Laparoscopic Adjustable Gastric Banding.
Davtyan C, Davtyan D. Consultant, 2004, 44(8): 1101-1103
-
Multivariate Analysis of the Relationship between Survival and the Microstage of Primary Melanoma by Clark Level and Breslow Thickness
Morton DL, Davtyan DG, Wanek LA et al, Cancer 1993,71(11): 3737-3743
-
Prolongation of Survival in Metastatic Melanoma after Active Specific Immunotherapy with a New Polyvalent Melanoma Vaccine
Morton DL, Foshag LJ, Hoon DSB, Nizze JA, Wanek LA, Chang C, Davtyan DG et al, Annals of Surgery 1992,216(4): 463-482
-
Modulation of Tumor Infiltrating Lymphocytes (TIL) in Melanoma after Active Specific Immunotherapy
Davtyan, DG, Hoon D, Morton DL, AACR Proceedings 1991 V-32, 252